Krsnaa Diagnostics Limited (NSE:KRSNAA)

Market Cap	18.25B -21.7%
Revenue (ttm)	7.66B +9.9%
Net Income	803.87M +6.3%
EPS	24.46 +7.2%
Shares Out	32.44M
PE Ratio	23.00
Forward PE	15.00
Dividend	2.75 (0.49%)
Ex-Dividend Date	Sep 12, 2025

Volume	35,455
Average Volume	62,143
Open	562.45
Previous Close	561.90
Day's Range	560.35 - 568.95
52-Week Range	515.00 - 894.40
Beta	0.10
RSI	37.67
Earnings Date	May 25, 2026

About Krsnaa Diagnostics

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves indivi...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2010
• Employees: 3,471
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: KRSNAA

Financial Performance

In fiscal year 2025, Krsnaa Diagnostics's revenue was 7.17 billion, an increase of 15.74% compared to the previous year's 6.20 billion. Earnings were 776.08 million, an increase of 36.54%.